Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

作者:Farfan Portet Maria Isabel*; Gerkens Sophie; Lepage Nefkens Isabelle; Vinck Irmgard; Hulstaert Frank
来源:The European Journal of Health Economics, 2014, 15(3): 223-228.
DOI:10.1007/s10198-013-0538-4